Altium Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Altium Capital Management’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,132,000	Closed	-$8.15M	–	106
2023 Q1	$8.15M	Hold	1,132,000	–	–	4.52%	4
2022 Q4	$9.31M	Hold	1,132,000	–	–	4.73%	4
2022 Q3	$12M	Buy	1,132,000 +220,000	+24%	+$2.34M	4.38%	1
2022 Q2	$8.43M	Sell	912,000 -538,006	-37%	-$4.4M	3.37%	2
2022 Q1	$9.98M	Hold	1,450,006	–	–	3.34%	3
2021 Q4	$11.7M	Sell	1,450,006 -338,783	-19%	-$2.25M	3.22%	3
2021 Q3	$11M	Hold	1,788,789	–	–	2.88%	2
2021 Q2	$5.56M	Buy	1,788,789 +215,400	+14%	+$823K	1.29%	22
2021 Q1	$6.04M	Sell	1,573,389 -109,146	-6%	-$414K	1.68%	9
2020 Q4	$5.15M	Buy	+1,682,535	New	+$4.56M	1.92%	10

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Altium Capital Management's BLU Position: Q2 2023 in Review

Altium Capital Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 1,132,000 shares — an estimated $8.15M sold.

Altium Capital Management first reported a position in BLU in Q4 2020 and held it in 10 quarters. The position peaked at $12M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Altium Capital Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Altium Capital Management sold 1,132,000 BELLUS Health Inc. shares in Q2 2023, an estimated $8.15M.
Altium Capital Management first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 10 quarters.
Altium Capital Management's BELLUS Health Inc. position peaked at $12M in Q3 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Altium Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.